Palisade Bio, Inc. (PALI) Insider Trading
Over the last 3 months, PALI insiders made 6 open-market buys and 2 sales, a net sale of -$160K (SEC Form 4). Over the last 6 months, 27 institutions increased and 29 reduced their position (13F).
Insider Activity
Sentiment
34/100
Buys (3m)
6
Sells (3m)
2
Net (3m)
-$159.7K
Insiders buying
Insider trades by month Buys Sells
Sep
Feb
May
Jan
Feb
Jul
Context3-month price +9.2%Institutions reducing (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 10, 2026 | Baltera Robert Jr.director | Buy | 25,000 | $1.96 |
| Jul 10, 2026 | Baltera Robert Jr.director | Buy | 20,000 | $1.99 |
| Jul 8, 2026 | Finley John Daviddirector, officer: CEO, CFO | Option | 133 | $0.70 |
| Jul 8, 2026 | Finley John Daviddirector, officer: CEO, CFO | Sell | 146,798 | $2.07 |
| Jul 8, 2026 | Jones Mitchell Lawrenceofficer: Chief Medical Officer | Sell | 51,880 | $2.05 |
| Jul 8, 2026 | Jones Mitchell Lawrenceofficer: Chief Medical Officer | Option | 131,167 | — |
| Jul 8, 2026 | Finley John Daviddirector, officer: CEO, CFO | Option | 335,167 | — |
| Jul 8, 2026 | Baltera Robert Jr.director | Buy | 30,000 | $2.03 |
| Jul 8, 2026 | Baltera Robert Jr.director | Buy | 20,000 | $2.05 |
| Jul 6, 2026 | Baltera Robert Jr.director | Buy | 20,000 | $1.98 |
| Jul 6, 2026 | Baltera Robert Jr.director | Buy | 10,000 | $1.98 |
| Jun 18, 2026 | Baltera Robert Jr.director | Grant | 336,904 | — |
| Jun 12, 2026 | Zwick Jordan Michaeldirector | Grant | 336,904 | — |
| Jun 12, 2026 | Chuang Emildirector | Grant | 592,300 | — |
| Jun 12, 2026 | Wei Binxiandirector | Option | 20,200 | — |
| Jun 12, 2026 | Wei Binxiandirector | Grant | 592,300 | — |
| Jun 12, 2026 | Williams Donald Allendirector | Option | 60,666 | — |
| Jun 12, 2026 | Williams Donald Allendirector | Grant | 1,498,900 | — |
| Jun 12, 2026 | Chuang Emildirector | Option | 20,200 | — |
| Feb 13, 2026 | Jones Mitchell Lawrenceofficer: Chief Medical Officer | Option | 8,000 | — |
| Feb 13, 2026 | Finley John Daviddirector, officer: CEO, CFO | Option | 13,333 | — |
| Feb 13, 2026 | Jones Mitchell Lawrenceofficer: Chief Medical Officer | Sell | 1,989 | $1.75 |
| Feb 13, 2026 | Finley John Daviddirector, officer: CEO, CFO | Sell | 3,896 | $1.75 |
| Feb 11, 2026 | Finley John Daviddirector, officer: CEO, CFO | Grant | 2,011,000 | — |
| Feb 11, 2026 | Jones Mitchell Lawrenceofficer: Chief Medical Officer | Grant | 787,000 | — |
| Jan 21, 2026 | Williams Donald Allendirector | Buy | 5,000 | $1.67 |
| Jan 13, 2026 | Williams Donald Allendirector | Buy | 5,000 | $1.88 |
| Nov 6, 2025 | Wei Binxiandirector | Grant | 60,600 | — |
| Nov 6, 2025 | Chuang Emildirector | Grant | 60,600 | — |
| Nov 6, 2025 | Williams Donald Allendirector | Grant | 182,000 | — |
Source: PALI SEC Form 4 filings, latest Jul 10, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their PALI positions over the last 6 months (SEC Form 13F).
Increased
27
New positions
36
Reduced
29
Sold out
97
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| AMERIPRISE FINANCIAL INC | Increased | 11.5M | Jul 17, 2026 |
| B GROUP, INC. | Increased | 11.4M | May 15, 2026 |
| JANUS HENDERSON GROUP PLC | Increased | 10.7M | May 18, 2026 |
| OCTAGON CAPITAL ADVISORS LP | Increased | 10.3M | May 15, 2026 |
| PERCEPTIVE ADVISORS LLC | Reduced | 8.9M | May 29, 2026 |
| COMMODORE CAPITAL LP | Reduced | 7.2M | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 7.1M | May 15, 2026 |
| FRANKLIN RESOURCES INC | Increased | 5.8M | May 13, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 5.4M | May 15, 2026 |
| EVERSEPT PARTNERS, LP | Reduced | 5.0M | May 15, 2026 |
| BOXER CAPITAL MANAGEMENT, LLC | Unchanged | 4.8M | May 15, 2026 |
| MORGAN STANLEY | Reduced | 4.6M | May 15, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Unchanged | 4.5M | May 15, 2026 |
| GREAT POINT PARTNERS LLC | New Position | 3.4M | May 15, 2026 |
| BALYASNY ASSET MANAGEMENT L.P. | Increased | 3.3M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.